Literature DB >> 27100832

Systematic Review and Meta-Analysis on Incidence of Altered Sensation of Mandibular Implant Surgery.

Chia-Shu Lin1, Shih-Yun Wu2,1, Hsin-Yi Huang3, Yu-Lin Lai1,4.   

Abstract

Altered sensation (including paresthesia, dysesthesia and hypoesthesia) after mandibular implant surgery may indicate transient or permanent injury of the inferior alveolar nerve and the mental branch, and considerably lower patients' satisfaction about the therapy. Previous studies have shown a great degree of variability on the incidence of altered sensation. We here reported the incidence of altered sensation after mandibular implant surgery based on a meta-analysis of 26 articles published between 1990.1.1 and 2016.1.1. Study quality and risk of bias was assessed and the studies with a lower score were excluded in the meta-analysis. Data synthesis was performed using the logistic-normal random-effect model. The meta-analyses revealed that the short-term (10 days after implant placement) and long-term (1 year after implant placement) incidence was 13% (95% CI, 6%-25%) and 3% (95% CI, 1%-7%), respectively. (2) For the patients who initially reported altered sensation, 80% (95% CI, 52%-94%) of them would return to normal sensation within 6 months after surgery, and 91% (95% CI, 78%-96%) of them would return to normal sensation one year after surgery. We concluded that dentist-patient communication about the risk of altered sensation is critical to treatment planning, since the short-term incidence of altered sensation is substantial (13%). When a patient reports altered sensation, regular assessment for 6 months would help tracing the changes of symptoms. In terms of long-term follow-up (1 year after surgery), the incidence is much lower (3%) and most patients (91%) would return to normal sensation.

Entities:  

Mesh:

Year:  2016        PMID: 27100832      PMCID: PMC4839635          DOI: 10.1371/journal.pone.0154082

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

One of the most disturbing complications associated with implant surgery is post-operative altered sensation, including paresthesia, dysesthesia and hypoesthesia [1,2]. For mandibular implant surgery, altered sensation may be associated with an injury of the inferior alveolar nerve (IAN) and the mental branch. Persistent altered sensation may indicate neurosensory dysfunction or IAN neuropathy [3,4]. Even transient altered sensation, such as numbness or tingling, may considerably lower patients’ satisfaction about implant surgery and, occasionally, result in medico-legal problems [2,5]. Therefore, the occurrence of post-operative altered sensation, such as paresthesia, has been widely considered as one of the success criteria of implant surgery [6,7], and recently, the diagnosis and prevention of altered sensation have been extensively discussed in the literature [1,8,9]. The occurrence of altered sensation has been investigated in previous reviews, as one of the general complications of implant surgery [10-12]. However, an estimation of the incidence of altered sensation after mandibular implant surgery, based on systematic review and meta-analysis, has not been reported. Based on clinical literature, the incidence of altered sensation varied considerably across studies, from 0.13% [13] to 37% [14]. Therefore, researchers can only estimate the incidence with a great degree of variability, such as 0–15% [8] or 0–40% [15]. In addition, the recovery rate of altered sensation, i.e. the proportion of the patients with altered sensation returning to normal sensation, has still remained unclear. More precise estimates of the incidence and the recovery rate of altered sensation, based on meta-analysis, would contribute to the risk assessment of surgery and patient-dentist communication, during treatment planning. Finally, elderly patients usually have a severely atrophic ridge, with a short distance between the ridge and the IAN [16,17]. The influences of patients’ age and the degree of ridge atrophy on the incidence of altered sensation have not been fully assessed. The current systematic review and meta-analysis aimed to estimate the incidence of altered sensation after mandibular implant surgery. Specifically, we focused on the following aims: First, we estimated the short-term (assessed postoperatively or within 10 days after implant placement) and long-term (assessed 1 year after implant placement) incidence of altered sensation after mandibular implant surgery. Secondly, we estimated the recovery rate of initial altered sensation, i.e., the proportion of the patients with altered sensation returning to normal sensation.

Materials and Methods

The review and meta-analysis were performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses for Protocols (PRISMA-P, see S1 Table for the checklist) [18]. The review protocol has been registered based on PROSPERO (http://www.crd.york.ac.uk/PROSPERO) (CRD42015016250) and the review was performed accordingly.

Eligibility Criteria

We selected the original research articles based on the following criteria: Participants: The participants included in the review were the adults who were eligible for implant surgery, according to the criteria established in the individual studies. All participants received mandibular implant surgery. Outcomes: The individual studies should report the number of patients who showed altered sensation. Our primary outcome was the incidence of altered sensation, defined as the proportion (i.e., the event rate) of the number of patients who showed altered sensation to the number of total patients being assessed after the surgery. ‘Altered sensation’ was identified if one of the following conditions was reported: dysesthesia, paresthesia (including changes in sensation, such numbness or tingling), hypoesthesia, anesthesia, or sensory changes as assessed by sensory testing [9]. The outcomes were further categorized according to the time point of clinical assessment. We considered the altered sensation recorded postoperatively or within 10 days after implant placement to be short-term, and the altered sensation recorded 1 year after implant placement to be long-term. Additionally, we considered the altered sensation recorded 3–6 months after implant placement to be intermediate-term, based on the model of nerve injury [19]. The articles that reported altered sensation during the period other than the previous time points would still be included. The model predicts that spontaneous healing would occur within 4 months, if nerve sheet is not damaged by trauma (i.e., neuropraxia and axonotmesis) [19,20].

Search Strategy

We performed a computerized search of original research articles on the electronic database MEDLINE and The Cochrane Library, with the keywords related to implant surgery and altered sensation. It should be noted that, because the term ‘altered sensation’ may refer to different experiences in studies, we included a variety of keywords related to altered sensation in our search, including allodynia, hyperalgesia, dysesthesia, paresthesia, sensory disturbance, numbness etc. (see Table 1 for the complete search strategy). Additionally, a manual search was performed by screening the reference list from the previous reviews on implant-related altered sensation [12,21,22]. The findings from the computerized and the manual search were pooled for subsequent selection. Search was limited to the journal articles published in English, during the period from 1990 Jan.1 to 2016 Jan. 1. Case reports were excluded.
Table 1

Search Strategy.

(A) Computerized search on PubMed/MEDLINE
SearchQueryItems found
#1Search (dental OR oral OR "inferior alveolar nerve") AND (implant OR implants)42409
#2Search ("altered sensation" OR allodynia OR hyperalgesia OR dysaesthesia OR paresthesia OR (sensory disturbance*) OR numbness OR (neurosensory disturbance*) OR "psychological impact" OR "nerve injury" OR neuropathic)63147
#3Search (#1 AND #2)314
#4Search (#3 NOT "case reports"[ptyp])266
#5Search (#3 NOT "case reports"[ptyp]) Filters: Publication date from 1990/01/01 to 2016/01/01; Humans; English182
(B) Computerized search on Cochrane Library
Publication Year from 1990 to 2016, in Trials, Methods Studies and Technology Assessments
SearchQueryItems found
#1Search (dental OR oral OR "inferior alveolar nerve") AND (implant OR implants)2730
#2Search ("altered sensation" OR allodynia OR hyperalgesia OR dysesthesia OR paresthesia OR "sensory disturbance" OR numbness OR "neurosensory disturbance" OR "psychological impact" OR "nerve injury")4716
#3Search (#1 AND #2)19
#4Publication year from 1990/01/01; English17

Study Selection

We manually screened the initially found articles by excluding those who focused on the following topics: transmandibular implant surgery, zygomatic or orbital implant surgery, nerve transposition, nerve lateralization, distraction osteogenesis, osteotomy for orthodontic purposes, or the bone-harvesting surgery without implant placement. The articles that no full text can be retrieved, according to PubMed, were also excluded (Fig 1). Review articles were excluded. Two authors (CSL and SYW) independently conducted literature search and the assessment of eligibility and study selection, primarily according to the title and the abstract of the selected articles. Decisions were made by a consensus between the authors. The selected articles were sorted using Endnote (Thomson Reuters, New York, NY, USA).
Fig 1

Flow diagram describing the process of review and study selection.

Data Collection and Extraction of Data Items

Printed or electronic full text of all the included studies was retrieved. The following data items were manually extracted: (A) Demographic and clinical characteristics (5 items, see Table 2), including (1) the design of the study (e.g., a randomized control trial of a retrospective/prospective cohort study), (2) the number of patients (total and by each sex), (3) the mean or the range of patients’ age, (4) patients’ ridge condition, focusing on alveolar bone height, the ridge-to-IAN canal distance (RCD), the Cawood’s class of mandible atrophy [23], and the Lekholm and Zarb’s class of jaw bone quality [24], (5) the surgical methods for ridge augmentation.
Table 2

Demographic and Clinical Characteristics of the Included Studies.

IDSourceDesign#Patient (Total/ Female/Male)1AgeRidge condition2Augmentation procedure
1Boven 2014[25]RS40/33/761Height 8.9±2.2 Atrophy VIIlliac crest onlay bone graft
2Kütük 2013[54]RS55/NRNRRCD ≥5NR
3Geckiki 2011[55]RS23/16/763NRNR
4Bormann 2010[33]NR13/8/556RCD >4Inter-positional autograft
5aFelice 2009a[36]3RCT15/11/456RCD 5–7Bio-Oss
5bFelice 2009a[36]3RCTRCD 5–7NR
6aFelice 2009b[35]RCT30/15/1555RCD 7–8Bio-Oss
6bFelice 2009b[35]RCT30/23/756RCD 7–8NR
7Burnstein 2008[37]NR20/NRNRRCD <10NR
8Vazquez 2008[13]PS1527/890/63753NRNR
9Abarca 2006[52]NR65(58)/30/3558NRNR
10van der Meij 2005[38]RS17/13/456Height 8.5 Atrophy VIIlliac crest onlay bone graft
11Visser 2005[56]RS60/39/2154.9Height 12–18 Atrophy V-VI Quality 3/2.75NR
12Frei 2004[57]PS50/30/2054Height 13.9±2.7NR
13Tortamano- Neto 2004[58]PS10(6)/5/528–61Sufficient bone volumeNR
14Walton 2000[59]PS75/47/2863NRNR
15Bartling 1999[41]PS94/43/51NRNRNR
16Allen 1997[40]RS60/ NRNRNRNR
17Friberg 1997[60]PS103/54/4959NRNR
18Wismeijer 1997[28]4PS110(105)/34/7651.5NRNR
19Batenburg 1994[61]RS57/40/1758Atrophy V-VINR
20Ellies 1993[21]RS112(87)/58/2958NRNR
21Ellies 1992[14]RS212/155/5757NRNR
22Johns 1992[26]PS133/79/5457Quality 1–36NR
23Åstrand 1991[62]NR23/15/857.7NRNR
24Kiyak 1990[53]PS39(27)/31/857.5NRNR
25van Steenberghe 1990[27]PS159/92/6741–60Quality 3–47NR
26Zarb 1990[63]NR46/36/10NRNRNR

NR: not reported; PS, prospective cohort study; RCD: ridge-to-canal distance; RCT, randomized control trial; RS, retrospective cohort study.

1The number in the brackets denotes the number of responders.

2Degree of bone atrophy was assessed by Cawood's classification; degree of bone quality was assessed by Lekholm and Zarb's classification; RDC and height is measured in mm.

3The study adopted a within-subject split-mouth design.

4Mean age was calculated based on Table 1 of the study.

5Bone quality was assessed respectively for two study groups.

6Most implants were placed with bone quality between 1 and 3, based on Table 5 of the study.

7The bone quality of 57% of the mandibles was of grade 3 or 4.

NR: not reported; PS, prospective cohort study; RCD: ridge-to-canal distance; RCT, randomized control trial; RS, retrospective cohort study. 1The number in the brackets denotes the number of responders. 2Degree of bone atrophy was assessed by Cawood's classification; degree of bone quality was assessed by Lekholm and Zarb's classification; RDC and height is measured in mm. 3The study adopted a within-subject split-mouth design. 4Mean age was calculated based on Table 1 of the study. 5Bone quality was assessed respectively for two study groups. 6Most implants were placed with bone quality between 1 and 3, based on Table 5 of the study.
Table 5

Criteria of Assessment of Study Quality and Risk of Bias.

Original NOQS itemsModified itemsScoring
YesUnclear
Representativeness of the exposed cohort(1)Are the inclusion and exclusion criteria explicitly stated?10
(2)Are the clinical features of the cohort explicitly stated?10
Ascertainment of exposure(3)Are the surgical procedures explicitly stated?10
Demonstration that outcome of interest was not present at start of study(4)Are the methods of assessment of altered sensation explicitly stated?10
Assessment of outcome(5)Are the experiences of altered sensation explicitly defined?10
Was follow-up long enough for outcomes to occur(6)Is the duration of follow-up explicitly stated?10
Adequacy of follow up of cohorts(7)Is the general success/survival rate of implant placement explicitly stated?10
7The bone quality of 57% of the mandibles was of grade 3 or 4. (B) Methodological characteristics (4 items, see Table 3), including (1) the length and diameter of implant (2) pre-operative imaging examination, focusing on the use of panoramic radiograph or tomograph/computed tomography, (3) the methods for assessing altered sensation, and (4) the specific experience of altered sensation (e.g., paresthesia or hypoesthesia) being assessed.
Table 3

Methodological characteristics of the included studies.

IDImplant (Length/ Diameter) *Preoperative imaging examinationAssessment of altered sensationExperience of altered sensation
1>10/4.1NRlight touch test, pin-prick testsensory change
2NRPanomechanoceptive testpain (tingling / throbbing)
3NRPanoNRpain, paresthesia
46-12/3.3–4.5Pano, DVTNRhypoesthesia
5a10-13/4CTNRparesthesia
5b5/6CTNRparesthesia
6a>10/NRCTNRparesthesia
6b7/NRCTNRparesthesia
7>5/NRNRNRNR
86-12/NRPano2-point discrimination, pin-prick testhypoesthesia, anesthesia, paresthesia
9NRNRquestionnaire, 2-point discrimination, light touch test, thermal testneurosensory disturbance
1013-15/3.8–4.5PanoNRneurosensory disturbance
1111-15/NRNRNRNR
128-12/4.1–4.8Pano, spiral tomograhNRparesthesia
1310/4.1NRNRpain, paresthesia
14NRPanoquestionnaire, light touch testnumb, tingling, painful etc.
15NRPano, CT2-point discrimination, light touch test, thermal testaltered sensation, anesthesia
16NRNRNRdysesthesia
177-20/3.75–4NRNRdisturbed nerve sensation
18NRNRquestionnaire, light touch test, pin-prick testhypersensitivity, anesthesia
1910-15/3.3–4Panolight touch testdysesthesia, hypoesthesia, anesthesia
20NRNRquestionnaireburning, painful etc.
21NRNRquestionnaireburning, painful etc.
22NRPanoNRparesthesia
23NRPano, tomographNRhypoesthesia, anesthesia
24NRNRquestionnaireNR
257-20/3.75–4PanoNRparesthesia
26NRPanoNRNR

CT: computed tomography; DVT: digital volume tomograph; NR: not reported; Pano: panoramic radiograph.

*All implant length and diameter is measured in mm.

CT: computed tomography; DVT: digital volume tomograph; NR: not reported; Pano: panoramic radiograph. *All implant length and diameter is measured in mm. (C) Outcomes of altered sensation (4 time points and 3 items for each time point, see Table 4), including (1) the time point when the investigation was performed, (2) the number of the patients initially showing altered sensation, and (3) the number of total patients being investigated, and. The data were extracted separately for short-term, intermediate-term, long-term outcomes, and the outcomes reported at other time point. Therefore 12 items in total were recorded (Table 4).
Table 4

Outcomes of the included studies.

Short-termIntermediate-termLong-termOther time point of assessment
IDTime point of assessment#Patients*Time point of assessment#PatientsTime point of assessment#PatientsTime point of assessment#Patients
1postsurgical11/40NRNRNRat their last recall visit (>5 year)5/40
2postoperative10/55follow-up continued for >6 months5/55follow-up continued for 2 years4/55
3NRNRNRNRNRNR3-year follow-up0/23
4NRNRNRNRNRNRNRNRNRnot explicitly specified5/13
5aafter implant placement1/15NRNRNRNRNRNR
5bafter implant placement3/15NRNRNRNRNRNR
6apostoperative16/30NRNRNRNRNRNR
6bpostoperative2/30NRNRNRNRNRNR
7postoperative0/20NRNRNRNRNRNR
81 week after surgery2/1527NRNRNRNRNRNR
9NRNRNRNRNRNRNRNRNRafter implant placement (8–24 months)19/58
10NRNRNRNRNRNR5.5 years after treatment1/17
11NRNRNRNRNRNR1 year after prosthesis placement0/60
12postoperative2/50NRNRNRNRNRNR
13NRNRNR6 months after surgery0/61 year after surgery0/6
14NRNRNR6 months after surgery3/751 year after surgery1/75
15within 1 week of surgery8/94121 days after surgery0/94NRNRNR
16postoperative11/50NRNRNRNRNRNR
17NRNRNRNRNRNRNRNRNRduring the entire study period; not-explicitly specified1/103
1810 days after surgery11/103NRNRNR16 months after surgery10/102
19NRNRNRNRNRNR12–57 months after loading0/57
201 week after surgery24/87> 3 months duration4/87> 1 year duration1/87
211 week after surgery50/212> 3 months duration17/212> 1 year duration4/212
22after implant placement19/103NRNRNR1 year after surgery1/103
23NRNRNRNRNRNR2-year follow-up7/23
24NRNRNRNRNRNRNRNRNR2 weeks after phase 1 surgery14/32
25after implant placement16/91NRNRNR1 year after prosthesis placement6/91
26NRNRNRNRNRNRNRNRNRduring the 4–6 years observation after implant placement0/46

NR: not reported.

*The column ‘#patients’ denotes the number of patients who reported altered sensation / the number of patients who received implant placement.

NR: not reported. *The column ‘#patients’ denotes the number of patients who reported altered sensation / the number of patients who received implant placement. It is noteworthy that some of the studies have reported the occurrence of altered sensation from more than one time point. For example, 6 studies have reported both short-term and long-term outcomes from the same cohort of patients [14,21,25-28]. Statistically, this overlap would increase the dependency between the results of different time point (see Discussion). However, because it is common for the clinical studies to examine patients’ symptoms for more than one time point, we here separately treated the outcomes from the same studies for different analyses. For example, the results from the study by Boven et al. ([25]) would be analysed for both short-term and long-term altered sensation.

Assessment of Study Quality and Risk of Bias

Assessment of study quality and risk of bias was performed according to a 7-item customized assessment sheet, which was modified from the Newcastle-Ottawa Quality Scale (NOQS) [29], a scale specific for non-randomized cohort study. The customized scale assessed the representativeness of cases, the research methods and the outcomes, of an individual study (see Table 5 for details the items).

Data Synthesis

We calculated the pooled event rate using Metaprop [30], a Stata-based program specifically designed for binominal data. The confidence intervals (CIs) were calculated using an exact binominal approach. Conventionally, a proportion, such as the event rate of altered sensation, can be approximated by the normal distribution. However, when the proportions are close to the boundary (i.e., 0 and 1), the normal distribution may not be a good approximation of proportions [30]. We did not adopt the approximation approach, because in our meta-analysis, the event rates of altered sensation were 0 or 100% in several studies. Specifically, the analysis was performed based on Stata version 13.1, using the program metaprop_one[30]. We used the exact method (i.e., the option cimethod(exact)) to calculate the confidence intervals of each study. A random-effect analysis was performed, (i.e., with the option logit) so that a binomial distribution is used to model the within-study variability and the parameters were estimated using a maximum likelihood procedure. Two analyses were performed to estimate the incidence and the recovery rate of altered sensation: Analysis 1: We investigated the incidence of altered sensation by calculating the pooled event rate of altered sensation, using a random-effect model. The analysis was performed respectively for (1) short-term (within 10 days after surgery) and (2) long-term (more than 1 year) outcomes. Regarding the intermediate-term outcome, we only descriptively examined the results from systematic review. We did not perform a meta-analysis on this time point, since the definition about ‘intermediate-term’, as we defined here (3 to 6 months after surgery) can be too ambiguous, and therefore would result in great between-study heterogeneity. Between-study heterogeneity was assessed using τ2 statistics. Here the value τ is variance in incidence between studies (here treated as a random effect)[31,32]. Statistical significance of τ2 was assessed using a random-effect model vs. fixed-effect model likelihood ratio (LR) test. We adopted a random-effect model effect because of the statistical heterogeneity between the studies (see Results) and the clinical heterogeneity due to experimental design and sampling [31]. Analysis 2: We investigated the recovery rate of initial altered sensation. Recovery rate was defined as the ratio of the patients whose altered sensation restored to normal sensation to those who had reported altered sensation postoperatively. Recovery duration was defined as the time when the clinical assessment was performed and normal sensation was recorded. The pooled recovery rate was calculated, respectively, for recovery duration ≦ 6 months and recovery duration = 1 year, using a random-effect model. These outcomes from were extracted based on the descriptions of the results or discussion in the original articles. For example, in one study (Study ID = 4), the authors have explicitly stated that ‘the maximum duration of these sensory disturbances was 6 weeks’ [33]. Therefore, we considered that all the patients who initially reported altered sensation (5 patients) returned to normal sensation within 6 months.

Assessment of Publication Bias

The degree of publication bias was visualized with funnel plots, and the degree of asymmetry of the funnel plots were estimated based on the Egger’s regression test [34]. The analyses were performed using statistical software Comprehensive Meta-analysis 2 (Biostat, Engelwood, NJ).

Results

Results of Search and Study Selection

Our search yielded 196 articles, including 188 articles from computerized search and 8 articles from manual search (Fig 1). After screening, 170 articles were excluded for a variety of reasons (see S2 Table for the reasons of excluding the articles). 26 articles were finally included. Among these, 2 articles (Study ID = 5, 6) reported the findings about two different surgical procedures [35,36]. These articles were each considered as two studies, and thus 28 studies were included (Fig 1).

Demographic, Clinical and Methodological Characteristics of the Included Studies

As shown in Tables 2 and 3, the included studies demonstrated a considerable degree of heterogeneity in the demographic, clinical and methodological aspects. The studies were predominantly an observational cohort study. Regarding the demographic and clinical aspects (Table 1), there were more female patients recruited in the studies, and the age was relatively elder, mostly 40–60 y/o. Patients’ mandibular ridges were moderate-to-severely atrophic, with inadequate bone height and/or poor bone quality. Reduction in the ridge-to-IAN canal distance was noted in several studies [35-37]. Augmentation procedures were performed in 5 studies [25,33,35,36,38]. Regarding the methodological aspects (Table 3), in most studies, an implant with a regular size (i.e., >10mm in length and 3.75-5mm in diameter) [39] was used. Panoramic radiography was frequently taken preoperatively, either alone (n = 9) or together with tomograph/computed tomography (n = 4). Regarding the assessment of altered sensation, questionnaires were used in 6 studies, and sensory testing was performed in 8 studies, among which a light touch test was the most frequently performed (n = 6). Paresthesia was the most recognized experience of altered sensation (n = 10), followed by pain (n = 6), anesthesia (n = 5), hypoesthesia (n = 4), and dysesthesia (n = 2).

Study Quality and Risk of Bias

Based on the results of study quality and risk of bias assessment, we found 3 studies with a score between 0 and 2 (Study ID = 2, 7, 12), 4 studies with a score 3(Study ID = 13, 16, 20, 26), and 21 studies with a score between 4 and 7 (for details see S3 Table). The average score of the assessment was 4.1±1.4 (±standard deviation), based on our customized scale (Table 5). In general, the study quality and risk of bias was moderate, with a substantial degree of variability across the studies. Regarding the representativeness of sampling, 50% of the studies have provided clear information about both the inclusive and exclusive criteria of patient selection. 64% of the studies have clearly stated the source of patient sampling (e.g., from multiple centers or a single hospital). 79% of the studies have clearly stated the surgical methods for implant placement. Regarding outcome assessment, only 36% of the studies have clearly defined the experience of altered sensation before assessment, and 54% of the studies have clearly stated the methods for assessment. Finally, 68% and 64% of the studies have clearly stated the duration of follow-up and success/survival rate of surgery, respectively (for detailed results see S3 Table).

Analysis 1: Estimating the Short-term and Long-term Incidence of Altered Sensation

The meta-analyses included 16 studies for estimating the short-term incidence (Study ID = 1, 2, 5a, 5b, 6a, 6b, 7, 8. 12, 15, 16, 18, 20, 21, 22, 25), 6 studies for the intermediate-term incidence (Study ID = 2, 13, 14, 15, 20, 21) and 14 studies for the long-term incidence (Study ID = 1, 2, 3, 10, 11, 13, 14, 18, 19, 20, 21, 22, 23, 25) (Table 4). The results of the intermediate-term outcome were discussed descriptively. Additionally, in 5 studies (Study ID = 4, 9, 17, 24, 26) the time point of altered sensation assessment is not confined to the short-term, intermediate-term or long-term category. For example, one study (Study ID = 4) reported altered sensation in 5 out of 13 patients; however the time-point when the assessment of altered sensation was performed is not explicitly stated in the article [33]. The outcomes from these studies were categorized as ‘Other time point of assessment’ in Table 4. These outcomes would be discussed descriptively and not be included in the meta-analysis. It should be noted that the results of study quality and risk of bias showed a higher level of variance, which may influence the pooled estimation of incidence. Therefore, we conducted data synthesis after excluding the studies with a lower score (0–2) of the study quality and risk of bias assessment. After the adjustment, 3 studies (Study ID = 2, 7, 12) were excluded for the analysis of short-term incidence and 1 study (Study ID = 2) was excluded for the analysis of long-term incidence. The short-term incidence was 13% (95% CI, 6%-25%, Fig 2A) and the long-term incidence was 3% (95% CI, 1%-7%, Fig 2B). A significant degree of between-study heterogeneity was found for both the short-term analysis (LR test: χ2(1) = 348.2, p<0.01, τ2 = 2.13) and the long-term analysis (LR test: χ2(1) = 23.6, p<0.01, τ2 = 1.86). Without the adjustment for study quality and risk of bias, the short-term incidence was 11% (95% CI, 5%- 21%; LR test: χ2(1) = 350.9, p<0.01, τ2 = 2.07) and the long-term incidence was 3% (95% CI, 1%-7%; LR test: χ2(1) = 22.3, p<0.01, τ2 = 1.60).
Fig 2

Forest plots of the incidence of altered sensation.

(A) The short-term (within 10 days after surgery) incidence. (B) The long-term (1 year after surgery) incidence.

Forest plots of the incidence of altered sensation.

(A) The short-term (within 10 days after surgery) incidence. (B) The long-term (1 year after surgery) incidence.

Analysis 2: Estimating the Recovery Rate of Altered Sensation

Fifteen studies that provided the information about recovery rate were included in the analysis (for detailed results see Table 6). Note that the studies included in Analysis 2 (Table 6) may not be identical to the studies included in Analysis 1 (Table 4). For example, one study (Study ID = 16) reported the patients with postoperative altered sensation, but it did not explicitly state the duration that the patients recovered from altered sensation [40]. These studies were excluded in Analysis 2. For another example, one study (Study ID = 4) reported the duration of recovery, but it did not explicitly state the time point of assessment [33]. These studies (Study ID = 4, 9, 18) would be included in Analysis 2 but not in Analysis 1.
Table 6

Recovery rate and recovery duration.

IDRecovery duration (month)#Patients recovered to normal sensation#Patients reported altered sensationSource of the outcomesRecovery rate
160611p.629: ‘Eleven patients reported postsurgical sensory disturbances of the mental nerve (objectively and subjectively), five of whom still had a sensory disturbance in the chin region at their last recall visit, but the size of this region had diminished over time.’55%
21510p.e406: ‘Pain duration of the patients ranged from 1 month to 4 years. Neuropathic pain has continued only for 1 month in 50%, 6 months in 10%, and 2 years in 10% of the patients after the operation.’50%
26610Same as above60%
224710Same as above70%
41.555pp.556-557: ‘None of these patients complained of permanent sensory disturbances. The maximum duration of these sensory disturbances was 6 weeks.’100%
5a0.111p.278: ‘No permanent paraesthesia of the alveolar inferior nerve occurred, the longest lasting 3 days.’100%
5b0.133Same as above100%
81.522p.83: ‘The nerve-altered sensation lasted for 6 weeks and disappeared without treatment.’100%
931119p.272:‘The duration of this postsurgical neurosensory disturbance after the implant surgery was less than 3 months in 58% (n = 11)’58%
12122p.493: ‘The altered sensation in the lower lip and the skin area of the chin was present for about three weeks in patient one and four weeks in patient two. After that time, both patients reported normal sensation.’100%
1461518p.466: ‘Although approximately 24% of all subjects reported sensation changes at 2 weeks after stage 1 surgery, only approximately 4% still reported sensory changes at 6 months after initial surgery, dropping to about 1%, 12 months later.’83%
14121718Same as above94%
15488p.1410: ‘All patients had returned to normal nerve function by 121 days after implant placement.’100%
1816511Table 4145%
2011120Table 2 and p.676: ‘When transient changes in sensation were experienced, 90% of patients reported that the symptoms had resolved by 6 months (Table 2).’255%
2061820Same as above90%
20121920Same as above95%
2112451Table V and p.666: ‘Transient alterations in sensation had resolved by 6 months in more than 80% of patients; however, four patients reported symptoms that resolved after 2 to 3 years (Table V).’47%
2164251Same as above82%
21124751Same as above92%
22121819p.518: ‘One of the remaining patients still had signs of paresthesia after 1 year of function.’95%
25121016p.277: ‘One year after prosthesis placement, the reported complications were dominated by patients with prosthetic difficulties, such as loosening of gold screws and fractures of the resin material (n = 10). Furthermore, six patients still complained of remaining paresthesia.’63%

1According to Table 4, 11 patients reported altered sensation on at least on side immediately after implant treatment. Among the 11 patients (No. 47, 49, 59, 69, 73, 77, 80, 85, 86, 87, 98), 5 patients (No. 47, 49, 73, 80, 85) have recovered to normal sensation within 16 months after treatment. The exact duration of altered sensation was not available.

2Only the patients with transient altered sensation (n = 20) were considered here. The patients with persistent changes were excluded because the exact duration of altered sensation was not available from the article.

1According to Table 4, 11 patients reported altered sensation on at least on side immediately after implant treatment. Among the 11 patients (No. 47, 49, 59, 69, 73, 77, 80, 85, 86, 87, 98), 5 patients (No. 47, 49, 73, 80, 85) have recovered to normal sensation within 16 months after treatment. The exact duration of altered sensation was not available. 2Only the patients with transient altered sensation (n = 20) were considered here. The patients with persistent changes were excluded because the exact duration of altered sensation was not available from the article. As shown in Fig 3A, the studies have shown a declined incidence of altered sensation during the follow-up sessions. After the excluding the studies with a lower score (0–2) from the study quality and risk of bias assessment (Study ID = 2, 12), 9 studies (Study ID: 4, 5a, 5b, 8, 9, 14, 15, 20, 21) reported the recovery rate within 6 months after surgery with the pooled recovery rate 80% (95% CI, 52%-94%, Fig 3B). A significant degree of between-study heterogeneity (LR test: χ2(1) = 7.9, p<0.01, τ2 = 1.30) was found. Five studies (Study ID: 14, 20, 21, 22, 25) reported the recovery rate 1 year after surgery (Table 6), with the pooled recovery rate 91% (95% CI, 78%-96%, Fig 3C). The between-study heterogeneity was not statistically significant (LR test: χ2(1) = 2.26, p = 0.07, τ2 = 0.64). Without the adjustment for study quality and risk of bias, the recovery rate within 6 months was 77% (95% CI, 53%- 91%; LR test: χ2(1) = 7.0, p<0.01, τ2 = 1.05). The recovery rate for 1 year did not differ before and after adjustment, because no study was excluded in this analysis.
Fig 3

Recovery rate of altered sensation.

(A) The incidence of altered sensation through the duration of follow up. All the studies have assessed the occurrence of altered sensation for at least two different time points, according to the outcomes presented in Table 4. Study IDs of the included studies are shown in the legend. (B) The forest plot for the recovery rate, when recovery duration ≦ 6 months. (C) The forest plot for the recovery rate, when recovery duration = 1 year.

Recovery rate of altered sensation.

(A) The incidence of altered sensation through the duration of follow up. All the studies have assessed the occurrence of altered sensation for at least two different time points, according to the outcomes presented in Table 4. Study IDs of the included studies are shown in the legend. (B) The forest plot for the recovery rate, when recovery duration ≦ 6 months. (C) The forest plot for the recovery rate, when recovery duration = 1 year.

Publication Bias

Regarding the analysis of short-term and long-term incidence, the Egger’s regression test showed significant asymmetry (P = 0.03 and P = 0.03, respectively) of the funnel plot. Regarding the analysis of intermediate-term, Egger’s regression test did not show significant asymmetry (P = 0.13) of the funnel plot (see S1 Fig for the funnel plots).

Discussion

Summary of Major Findings

We here reported the incidence of altered sensation after mandibular implant surgery based on a meta-analysis of 26 articles (28 studies) between 1990 and 2016. We concluded three major findings: The short-term (within 10 days after surgery) and long-term (1 year after implant placement) incidence was 13% (95% CI, 6%-25%) and 3% (95% CI, 1%-7%), respectively (Fig 2). All studies have shown a declined incidence during the follow-up session (Fig 3A). When altered sensation was found immediately after surgery, within 6 months after surgery, 80% (95% CI, 52%-94%) of the patients would return to normal sensation (Fig 3B). One year after surgery, 91% (95% CI, 78%-96%) of them would return to normal sensation (Fig 3C).

Incidence of Altered Sensation and the Recovery Rate after Mandibular Implant Placement

Estimates of the incidence of altered sensation varied dramatically across previous studies. A frequently cited number is 8.5% according to Bartling and co-workers, based on the results of subjective assessment and sensory testing of 94 patients [41]. An earlier retrospective research by Ellies reported an incidence 37%, based on the questionnaires from 226 multi-center patients [14]. Another earlier systematic review by Berglundh and co-workers estimated that 41% of the 159 reviewed studies have reported an occurrence of persistent (lasting more than 1 year) sensory disturbance [10]. In contrast, according to Vazquez and co-workers, based on a larger cohort of patients (n = 1527), the incidence was very low (0.13%) [13]. Therefore, most researchers would estimate the incidence with a great degree of variability, such as 0–15% [8] or 0–40% [15]. The huge variation may be associated with the heterogeneity in research methods. While some studies only focused on persistent changes (e.g., disturbances lasting for more than 1 year), others focused on transient ones (e.g., disturbances occurring immediately after surgery). We here estimated the short-term and long-term incidence of altered sensation. As expected, the incidence decreased through the three time points. Our meta-analysis results are consistent with the neurophysiological model of nerve injury, which classified nerve injury into three major classes: neuropraxia, axonotmesis and neurotmesis [19,20]. A transient and reversible injury without damaging the nerve proper and nerve sheath i.e., neuropraxia or axonotmesis, would spontaneously return to normal sensation within 2 to 4 months, as shown in most of the cases of altered sensation after mandibular implant surgery [42,43]. Furthermore, we found the recovery rate was high (80%) for the first 6 months after implant placement. One year after implant placement, an even higher proportion of patients (91%) may return to normal sensation (Fig 3B). The findings suggested that, even though the short-term assessment showed a considerably high incidence (13%) of altered sensation, most of the cases would be resolved within 1 year.

Effects of Biological Risk Factors

The elderly patients usually have a severely atrophic ridge, with a short distance between the ridge and the IAN [16,17]. The influences of patients’ age and the degree of ridge atrophy on the incidence of altered sensation have not been fully assessed. The results from the review suggested that short ridge-to-IAN canal distance may not influence the short-term incidence of altered sensation. It should be noted that in 4 of the short-RCD studies (Study ID = 5a, 5b, 6a, 6b), either augmentation procedures were performed or a short implant (5mm or 7mm) was used, in order to compensate the inadequate bone height [35,36]. The finding suggested that ridge atrophy (RCD < 10mm) may not significantly increase the risk of altered sensation, given that augmentation procedures are performed or a shorter implant is used. The finding highlighted the importance of pre-surgery treatment planning. The anatomical relation between the implant and the IAN, especially the mental nerve branch, plays a critical role in the occurrence of altered sensation [42,43]. Imaging techniques, such as the computed tomography would be valuable tools for precisely evaluating the spatial relation between bone and nerve structures [44]. The problems are particularly critical to the elderly patients of implant surgery, because both the degree of ridge atrophy and bone quality is related with aging [45]. Our analysis did not reveal a significant association between age and the incidence of altered sensation. This negative finding implies that age per se may not have a direct effect on altered sensation. Instead, its effect may be associated with multiple factors, such as ridge morphology and bone quality/quantity. Interaction between these factors would require further investigation.

Limitations and Further Considerations

Due to the heterogeneity in study design, patient sampling and methods of assessment across the studies, conclusions from the current review and meta-analysis should be carefully interpreted with the following considerations: For the biological risk factors, we here only evaluated the effect of age and ridge-to-IAN canal distance, since these factors can be precisely quantified. However, we did not investigate the overall physical and behavioral conditions, such as diabetes and smoking, which are known associated with implant outcomes [46,47]. For example, diabetes is associated with altered pain sensitivity in the elderly patients [48]. As shown in the assessment of risk of bias, few studies have systematically evaluated these risk factors during patient sampling. The effect of these factors would require further investigation. Regarding the methods of assessment, we here did not differentiate the specific experiences of altered sensation. Clinically, dysesthesia or pain may indicate the development of neuropathy or a significant influence on patients’ quality of life [49,50]. However, because most studies did not clearly state how these experiences were defined to the patients, we here pooled all the symptoms under an umbrella term ‘altered sensation’. In addition, very few studies have investigated the quantity of altered sensation, for example, using a psychophysical scale (e.g., the numerical rating scale). Therefore, we cannot evaluate the change about the intensity of altered sensation through a period of time. Regarding the method of data synthesis, it should be noted that the estimates of short-term and long-term altered sensation were from some overlapped studies– 6 studies have reported both short-term and long-term results [14,21,25-28]. Although this is commonly seen in the clinical studies about post-surgical results, in which the authors would usually examine patients’ symptoms for more than one time point. The lack of independence may lead to an underestimation of standard errors and hence confidence intervals. It should be noted that, in terms of surgical procedure, both drilling and implant placement may induce IAN injury. However, the included studies did not distinguish between the two conditions. It has remained unknown whether drilling or placement is the dominant factor to IAN injury. Apart from the physical conditions, altered sensation is both a sensory and an emotional experience [51]. Very few studies have reported the emotional aspects about altered sensation, and the psychosocial profiles about patients with altered sensation were mostly under-researched (except for [52,53], for example). Importantly, when patients perceive altered sensation after surgery, the increased dissatisfaction and negative emotion may results in liability claims. The dissatisfaction would be greater if the risk of altered sensation is not notified before surgery. The association between the affective-motivational factors and the medico-legal claims have not been fully investigated.

Clinical Implications

Based on our findings, we suggested the following aspects about improving the quality of dental implant therapy. On dentist-patient communication about the risk of altered sensation: our findings showed that, for the implant surgery with conventional procedures, the risk to have altered sensation immediately after surgery is substantial (13%). Nevertheless, most of these initial symptoms would spontaneously return to normal. Our findings highlighted the importance of early assessment[11]. Importantly, when a patient reports altered sensation, regular assessment for 6 months would be critical to trace the changes of altered sensation. On the timing of assessment: our findings suggested that an assessment during 3 to 6 months postoperatively would be valuable for subsequent management of altered sensation. Our finding echoed the proposal that if the symptom does not reduce by the time of 12 weeks, further intervention (e.g., neurosurgical referral) may be considered [42,43]. We suggested that follow-up assessment should be scheduled no shorter than 6 months, since most patients with initial altered sensation may return to normal at that stage.

Publication Bias.

(TIF) Click here for additional data file.

PRISMA-P Checklist.

(DOCX) Click here for additional data file.

Reasons for Article Exclusion.

(DOCX) Click here for additional data file.

Results of Assessment of Study Quality and Risk of Bias.

(DOCX) Click here for additional data file.
  59 in total

1.  Implant dentistry at the focus of liability lawsuits.

Authors:  Ludger Figgener; Johannes Kleinheinz
Journal:  Int J Oral Maxillofac Implants       Date:  2004 May-Jun       Impact factor: 2.804

Review 2.  Success or failure of dental implants? A literature review with treatment considerations.

Authors:  Judith A Porter; J Anthony von Fraunhofer
Journal:  Gen Dent       Date:  2005 Nov-Dec

Review 3.  Trigeminal nerve injuries after mandibular implant placement--practical knowledge for clinicians.

Authors:  Frederick Hegedus; Robert J Diecidue
Journal:  Int J Oral Maxillofac Implants       Date:  2006 Jan-Feb       Impact factor: 2.804

Review 4.  Diabetes and oral implant failure: a systematic review.

Authors:  B R Chrcanovic; T Albrektsson; A Wennerberg
Journal:  J Dent Res       Date:  2014-06-13       Impact factor: 6.116

Review 5.  Persistent pain and neurosensory disturbance after dental implant surgery: prevention and treatment.

Authors:  Mohanad Al-Sabbagh; Jeffrey P Okeson; Elizangela Bertoli; Denielle C Medynski; Mohd W Khalaf
Journal:  Dent Clin North Am       Date:  2014-09-22

Review 6.  Addressing the atrophied mandible: a proposal for a treatment approach involving endosseous implants.

Authors:  Gerry M Raghoebar; Henny J A Meijer; Kess Stellingsma; Arjan Vissink
Journal:  Int J Oral Maxillofac Implants       Date:  2011 May-Jun       Impact factor: 2.804

7.  Altered sensation associated with implants in the anterior mandible: a prospective study.

Authors:  J N Walton
Journal:  J Prosthet Dent       Date:  2000-04       Impact factor: 3.426

8.  The combined use of two endosteal implants and iliac crest onlay grafts in the severely atrophic mandible by a modified surgical approach.

Authors:  E H van der Meij; J Blankestijn; R M Berns; R J Bun; A Jovanovic; J M Onland; J Schoen
Journal:  Int J Oral Maxillofac Surg       Date:  2005-03       Impact factor: 2.789

9.  Implant diameter and length influence on survival: interim results during the first 2 years of function of implants by a single manufacturer.

Authors:  Eitan Mijiritsky; Ziv Mazor; Adi Lorean; Liran Levin
Journal:  Implant Dent       Date:  2013-08       Impact factor: 2.454

10.  Influence of TRPV1 on diabetes-induced alterations in thermal pain sensitivity.

Authors:  Reddy M Pabbidi; Shuang-Quan Yu; Siying Peng; Romesh Khardori; Mary E Pauza; Louis S Premkumar
Journal:  Mol Pain       Date:  2008-03-01       Impact factor: 3.395

View more
  8 in total

1.  Persistent, neuropathic-like trigeminal pain after dental implant loading.

Authors:  Ndiaye Amadou-Diaw; Adeline Braud; Yves Boucher
Journal:  J Clin Exp Dent       Date:  2022-02-01

2.  Morphological and topographic evaluation of the mandibular canal and its relationship with the facial profile, skeletal class, and sex.

Authors:  Gustavo Moraes Prado; Rocharles Cavalcante Fontenele; Eliana Dantas Costa; Deborah Queiroz Freitas; Matheus L Oliveira
Journal:  Oral Maxillofac Surg       Date:  2022-03-18

3.  Oxytocin-Dependent Regulation of TRPs Expression in Trigeminal Ganglion Neurons Attenuates Orofacial Neuropathic Pain Following Infraorbital Nerve Injury in Rats.

Authors:  Masatoshi Ando; Yoshinori Hayashi; Suzuro Hitomi; Ikuko Shibuta; Akihiko Furukawa; Tatsuki Oto; Takanobu Inada; Tomoyuki Matsui; Chikashi Fukaya; Noboru Noma; Masakazu Okubo; Yoshiyuki Yonehara; Tadayoshi Kaneko; Koichi Iwata; Masamichi Shinoda
Journal:  Int J Mol Sci       Date:  2020-12-01       Impact factor: 5.923

4.  Effect of vitamin B complex administration on pain and sensory problems related to inferior alveolar nerve damage following mandibular implant placement surgery.

Authors:  Shima Ghasemi; Amirreza Babaloo; Mehrnoosh Sadighi; Zeinab Torab; Hamidreza Mohammadi; Elshan Khodadust
Journal:  J Adv Periodontol Implant Dent       Date:  2022-05-30

5.  CBCT Evaluation of Buccolingual Orientation of Inferior Alveolar Canal in Mandibular Posterior Region for Implant Planning.

Authors:  Michelle Kher Wei Chua; Wen Jiong Koh; Smita Nimbalkar; Pravinkumar G Patil
Journal:  Int J Dent       Date:  2022-08-27

6.  Macrophages in trigeminal ganglion contribute to ectopic mechanical hypersensitivity following inferior alveolar nerve injury in rats.

Authors:  Dulguun Batbold; Masamichi Shinoda; Kuniya Honda; Akihiko Furukawa; Momoko Koizumi; Ryuta Akasaka; Satoshi Yamaguchi; Koichi Iwata
Journal:  J Neuroinflammation       Date:  2017-12-16       Impact factor: 8.322

Review 7.  The Anatomical Nature of Dental Paresthesia: A Quick Review.

Authors:  Maha Ahmad
Journal:  Open Dent J       Date:  2018-02-22

8.  Increase in IGF-1 Expression in the Injured Infraorbital Nerve and Possible Implications for Orofacial Neuropathic Pain.

Authors:  Shiori Sugawara; Masamichi Shinoda; Yoshinori Hayashi; Hiroto Saito; Sayaka Asano; Asako Kubo; Ikuko Shibuta; Akihiko Furukawa; Akira Toyofuku; Koichi Iwata
Journal:  Int J Mol Sci       Date:  2019-12-17       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.